AU2003237031A1 - Ex-vivo gene therapy of diabetes using iap polypeptides - Google Patents

Ex-vivo gene therapy of diabetes using iap polypeptides

Info

Publication number
AU2003237031A1
AU2003237031A1 AU2003237031A AU2003237031A AU2003237031A1 AU 2003237031 A1 AU2003237031 A1 AU 2003237031A1 AU 2003237031 A AU2003237031 A AU 2003237031A AU 2003237031 A AU2003237031 A AU 2003237031A AU 2003237031 A1 AU2003237031 A1 AU 2003237031A1
Authority
AU
Australia
Prior art keywords
diabetes
gene therapy
vivo gene
iap polypeptides
iap
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003237031A
Inventor
Robert G. Korneluk
Peter Liston
Rusung Tan
Bruce Verchere
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of British Columbia
Aegera Therapeutics Inc
Original Assignee
University of British Columbia
Aegera Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of British Columbia, Aegera Therapeutics Inc filed Critical University of British Columbia
Publication of AU2003237031A1 publication Critical patent/AU2003237031A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
AU2003237031A 2002-01-23 2003-01-23 Ex-vivo gene therapy of diabetes using iap polypeptides Abandoned AU2003237031A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35078302P 2002-01-23 2002-01-23
US60/350,783 2002-01-23
PCT/IB2003/000597 WO2003061551A2 (en) 2002-01-23 2003-01-23 Ex-vivo gene therapy of diabetes using iap polypeptides

Publications (1)

Publication Number Publication Date
AU2003237031A1 true AU2003237031A1 (en) 2003-09-02

Family

ID=27613427

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003237031A Abandoned AU2003237031A1 (en) 2002-01-23 2003-01-23 Ex-vivo gene therapy of diabetes using iap polypeptides

Country Status (4)

Country Link
EP (1) EP1469889A2 (en)
AU (1) AU2003237031A1 (en)
CA (1) CA2472333A1 (en)
WO (1) WO2003061551A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110029130A (en) * 2019-04-24 2019-07-19 皖南医学院第一附属医院（皖南医学院弋矶山医院） Sidt2 genetic method is rejected in Beta-TC-6 cell strain based on CRISPR/Cas9 system

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5919912A (en) * 1995-08-04 1999-07-06 University Of Ottawa Mammalian IAP antibodies and diagnostic kits
US6171821B1 (en) * 1998-07-24 2001-01-09 Apoptogen, Inc. XIAP IRES and uses thereof

Also Published As

Publication number Publication date
WO2003061551A3 (en) 2003-11-13
WO2003061551A2 (en) 2003-07-31
EP1469889A2 (en) 2004-10-27
CA2472333A1 (en) 2003-07-31

Similar Documents

Publication Publication Date Title
AU2003230184A1 (en) Electrode assembly for nerve control
AU2003234529A1 (en) Glp-1 gene delivery for the treatment of type 2 diabetes
AU2003288586A1 (en) Electrode arrangement
AU2003901852A0 (en) Cochlear electrode array
AU2002226633A1 (en) Treatment of diabetes mellitus using vardenafil
AU2003256712A1 (en) Cyclic device for restructuring heart chamber geometry
AU2003229295A1 (en) Carbon coated battery electrodes
AU2003209226A1 (en) Adiponectin gene therapy
AU2003275026A1 (en) Induction of insulin expression
AU2003295890A1 (en) Anilinopyrazole derivatives useful for the treatment of diabetes
AU2003279442A1 (en) 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes
AU2003220410A1 (en) Airway assembly
AU2003207984A1 (en) Dual function nasal cannula
AU2003277910A1 (en) Ocular gene therapy
AU2003267809A1 (en) Powder inhaler
AU2003300277A1 (en) Association of molecules with electrodes of an array of electrodes
AU2003255612A1 (en) Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments
AU2003217956A1 (en) Therapeutic polypeptides, nucleic acids encoding same and methods of use
AU2003237031A1 (en) Ex-vivo gene therapy of diabetes using iap polypeptides
AU2003256931A1 (en) USES OF CIRCADIAN GENE mPER2
AU2002327440A1 (en) Treatment of type i diabetes
AU2003211523A1 (en) Electrode structural body
AU2002335304A1 (en) The use of berberine as insulin sensitizer
AU2002953223A0 (en) Novel therapeutic molecules and uses thereof
AU2003228802A1 (en) TGF-Alpha POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase